Impaired development of Th2 cells in IL-13-deficient mice

Immunity. 1998 Sep;9(3):423-32. doi: 10.1016/s1074-7613(00)80625-1.

Abstract

We report that Th2 cell cultures generated using T cells or splenocytes from IL-13-deficient mice produce significantly reduced levels of IL-4, IL-5, and IL-10 compared with wild-type. In contrast, IL-4 and IL-5 production by mast cells stimulated in vitro with PMA, ionomycin, or IgE cross-linking are unaffected. In vitro Th2 cell differentiation cannot be rescued by the addition of exogenous factors, but in vivo antigen challenge and administration of IL-13 can increase Th2-like cytokine responses as can infection with the parasitic nematode Nippostrongylus brasiliensis. IL-13-deficient mice also have lower basal levels of serum IgE and biased antigen-specific immunoglobulin responses. Thus, IL-13 is an important regulator of Th2 commitment and may therefore play a central role in atopy and infectious diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Lymphocytes / metabolism
  • CD4-Positive T-Lymphocytes / cytology
  • Cell Differentiation
  • Drug Resistance / genetics
  • Gene Targeting / methods
  • Immunization
  • Immunoglobulin E / blood
  • Interleukin-13 / deficiency*
  • Interleukin-13 / genetics
  • Interleukin-13 / physiology
  • Interleukin-4 / biosynthesis
  • Interleukin-5 / biosynthesis
  • Mast Cells / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mutagenesis, Insertional
  • Nematode Infections / immunology
  • Neomycin / pharmacology
  • Phosphoglycerate Kinase / genetics
  • Receptors, IgE / biosynthesis
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Spleen / cytology
  • Th2 Cells / cytology*
  • Th2 Cells / drug effects
  • Th2 Cells / metabolism

Substances

  • Interleukin-13
  • Interleukin-5
  • Receptors, IgE
  • Recombinant Proteins
  • Interleukin-4
  • Immunoglobulin E
  • Phosphoglycerate Kinase
  • Neomycin